Peng Xia to Receptors, Fibroblast Growth Factor
This is a "connection" page, showing publications Peng Xia has written about Receptors, Fibroblast Growth Factor.
Connection Strength
0.552
-
SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models. Acta Pharmacol Sin. 2018 Feb; 39(2):243-250.
Score: 0.362
-
Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-1-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors. Eur J Med Chem. 2018 Jun 25; 154:9-28.
Score: 0.190